• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Integrating PrEP into Iran Harm Reduction Offers Cost-Effective HIV Prevention

by
November 18, 2026
in Health
Reading Time: 6 mins read
0
Integrating PrEP into Iran Harm Reduction Offers Cost-Effective HIV Prevention

Integrating PrEP into Iran Harm Reduction Offers Cost-Effective HIV Prevention

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Integrating pre-exposure prophylaxis into existing harm reduction infrastructure represents a clinically viable and cost-effective approach to strengthening national HIV prevention in Iran, according to a narrative synthesis published in Discover Public Health. The synthesis highlights that while pre-exposure prophylaxis, widely known as PrEP, serves as an internationally recognized biomedical intervention capable of substantially reducing HIV transmission, it has not yet been formally incorporated into Iran’s national health strategy. By examining the operational mechanisms of current harm reduction programs, the authors report that embedding daily antiretroviral prophylaxis into routine public health delivery could bridge persistent service gaps. Rather than establishing entirely independent delivery networks, utilizing existing clinical contact points offers a sustainable mechanism to curb transmission across vulnerable cohorts. The analysis demonstrates that combining preventive pharmacotherapy with established harm reduction services yields favorable economic outcomes while expanding health coverage across key populations that face elevated exposure risks.

The study was conducted by researchers Hossein Moameri, Mohammad Karamouzian, Parya Saberi, and Hamid Sharifi, who synthesized evidence gathered through structured literature searches across PubMed, Scopus, and Web of Science covering the period from 2010 through 2025. To capture local implementation contexts and policy frameworks, the research team supplemented peer-reviewed literature with official documents from the World Health Organization, the Joint United Nations Programme on HIV/AIDS, and the Iranian Ministry of Health, along with programmatic records from domestic harm reduction facilities. Applying a narrative synthesis methodology, the investigators categorized existing evidence into operational barriers, systemic facilitators, and economic considerations within Iran’s health system. The analytical framework evaluated how clinical and structural data intersect with domestic healthcare realities, assessing the feasibility of introducing antiretroviral prevention without requiring destabilizing capital expenditures. The resulting assessment provides an evidence-based roadmap designed to help policymakers, clinical providers, and healthcare stakeholders formulate targeted preventative initiatives.

Pre-exposure prophylaxis operates as a preventative regimen utilizing antiretroviral medications among HIV-seronegative individuals facing high acquisition probabilities, a strategy formally recommended by the World Health Organization since 2012. Extensive international clinical studies have consistently documented that PrEP regimens are safe, well-tolerated, and highly effective at preventing HIV acquisition across diverse exposure categories. Multiple countries, including the United States, France, Brazil, and South Africa, have successfully authorized and deployed PrEP programs targeting populations with high incidence rates. Despite these global endorsements and demonstrated biomedical efficacy, real-world implementation across resource-constrained settings frequently encounters complex societal, structural, and financial impediments. In Iran, although preliminary surveys indicate substantial user interest among vulnerable groups, formal integration into the central HIV prevention framework has remained absent. Consequently, the healthcare system has experienced an ongoing missed opportunity to exploit established harm reduction channels to achieve comprehensive epidemic control.

Iran maintains a well-developed network of specialized harm reduction facilities, specifically centered around Drop-In Centers and Voluntary Counseling and Testing centers designed to serve key populations. These existing public health facilities historically concentrate their interventions on cohorts with elevated exposure profiles, specifically people who inject drugs, female sex workers, and men who have sex with men. The operational scope of these community-facing centers encompasses confidential HIV testing, diagnostic counseling, free condom distribution, needle-syringe exchange programs, and opioid agonist therapy such as methadone maintenance. Because these facilities already possess operational footprints, clinical protocols, and consistent interactions with vulnerable groups, they provide a logical logistical foundation for prophylaxis delivery. Embedding PrEP within these pre-existing facilities would eliminate the necessity of constructing parallel healthcare delivery channels, allowing clinical personnel to engage key populations during regular appointments for harm reduction or opioid substitution therapy.

Implementation of PrEP across Iran faces multi-level barriers spanning social stigma, financial constraints, and structural healthcare deficits. At the societal and interpersonal level, pervasive fear of stigma discourages individuals living with HIV or those at heightened risk from disclosing their status or engaging with preventative clinical services. Furthermore, provider-level stigma directed toward people who inject drugs, female sex workers, and men who have sex with men continues to compromise service delivery and clinical trust. From an economic standpoint, healthcare administrators harbor concerns regarding the immediate budgetary outlays associated with initiating new pharmaceutical programs, while prospective patients frequently struggle to afford regular transportation to specialized clinical centers. Structurally, generalized mistrust of healthcare institutions suppresses PrEP initiation, compounded by low awareness and inadequate pharmacological knowledge among healthcare practitioners, which diminishes clinical motivation to offer proactive prevention to qualified candidates.

The broader macroeconomic landscape in Iran introduces substantial complications to healthcare delivery and preventative financing, primarily driven by international sanctions and sustained economic instability. These financial pressures have severely constrained national healthcare budgets, leading to a marked devaluation of the Iranian Rial that has drastically diminished the Ministry of Health’s purchasing capacity for essential imported medications. Consequently, budgetary contractions have curtailed public awareness campaigns and reduced operational allocations for essential harm reduction programs, which are predominantly executed by non-governmental organizations operating under the administrative supervision and funding of the Ministry of Health and Welfare. The compounding economic distress heightens underlying social vulnerabilities, which can amplify engagement in high-risk behaviors while obstructing broader epidemiological control measures. These systemic financial challenges collectively threaten historical progress in domestic HIV containment, posing potential risks of elevated viral transmission rates and compromised long-term population health outcomes.

Economic evaluations reviewed in the synthesis demonstrate that integrating PrEP into established harm reduction networks remains a cost-effective public health strategy in Iran, even under constrained budgetary conditions. A specialized economic modeling study focusing on female sex workers in Iran revealed that although the annual cost of PrEP reached 352.90 US dollars per person—a figure higher than comparable estimates documented in several other countries—pairing prophylaxis with needle-syringe programs and opioid agonist therapy remained highly cost-effective. Consolidating clinical interventions within existing facilities circumvents the prohibitive financial burdens associated with building new independent facilities or employing separate administrative and clinical cadres. Nevertheless, securing the long-term durability of PrEP over the coming decade will necessitate a multi-faceted financing architecture that integrates sustained domestic government funding commitments, international support mechanisms, and strategic private-sector collaboration to ensure that economically marginalized individuals receive services free of charge.

The review identifies critical facilitators that can be leveraged to accelerate PrEP integration, prominently highlighting the behavioral dynamics of Generation Z, defined as individuals born between the mid-to-late 1990s and the early 2010s. Empirical research indicates that younger people who inject drugs in Iran exhibit significantly greater interest in PrEP compared to older demographic cohorts, mirroring international observations that document young people’s proactive motivation to safeguard personal health and mitigate infectious risks. Furthermore, indigenous social support structures, encompassing immediate family members, peers, and intimate partners, provide vital emotional and practical reinforcement that diminishes the stigma surrounding HIV prevention programs. Partner support, in particular, exerts a statistically notable positive influence on PrEP initiation. Coupled with the familiarity and physical accessibility of existing Drop-In Centers and Voluntary Counseling and Testing sites, these sociocultural and structural facilitators provide an actionable foundation for community-wide uptake.

To translate these facilitators into functional delivery models, the authors propose targeted service distribution pathways tailored to the specific behavioral and social contexts of distinct key populations. Drop-In Centers, which already distribute clean needles and dispense methadone, represent the optimal clinical point for reaching people who inject drugs, while Voluntary Counseling and Testing centers present an appropriate setting for serving female sex workers. The authors also highlight triangular clinics operating within Iranian prisons and detention centers, where needle exchanges and opiate substitution therapies are established, as vital environments to reach institutionalized individuals who cannot access community-based clinics. For men who have sex with men, who currently lack dedicated municipal health centers in Iran, the authors recommend alternative delivery through private medical practices, community pharmacies, and sexual health screening packages, potentially supported by partnerships with international generic pharmaceutical manufacturers to reduce drug procurement costs.

The authors note two central methodological limitations inherent in their analysis, observing first that published empirical investigations examining PrEP implementation within Iran remain exceptionally scarce, which forced the synthesis to draw extensively on international literature supplemented by available programmatic data and gray literature. Second, because the published work represents an analytical viewpoint and evidence synthesis, no primary empirical or clinical trial data were directly collected by the investigators. Future initiatives must prioritize domestic implementation studies and rigorous behavioral surveys across key populations and clinical personnel to establish granular, context-specific evidence regarding therapeutic adherence, social acceptability, and optimized delivery workflows. Ultimately, overcoming multi-level implementation hurdles through national clinical guidelines, dedicated public funding, provider training, and robust community engagement could allow Iran to integrate PrEP sustainably, thereby advancing toward national HIV elimination goals and contributing to the global UNAIDS 2030 targets.

Subject of Research: Integration of pre-exposure prophylaxis into harm reduction infrastructure for HIV prevention in Iran

Article Title: Integrating pre-exposure prophylaxis into harm reduction programs as a sustainable approach to HIV prevention in Iran

Article References: Moameri, H., Karamouzian, M., Saberi, P., & Sharifi, H. (2026). Integrating pre-exposure prophylaxis into harm reduction programs as a sustainable approach to HIV prevention in Iran. Discover Public Health, 23(1), Article 1816. https://doi.org/10.1186/s12982-026-02819-9

Image Credits: AI Generated

DOI: 10.1186/s12982-026-02819-9

Keywords: pre-exposure prophylaxis, HIV prevention, Iran, harm reduction, drop-in centers, voluntary counseling and testing, people who inject drugs, female sex workers, men who have sex with men, cost-effectiveness, Generation Z, health system infrastructure, triangular clinics, social stigma, healthcare provider training, antiretrovirals, public health policy

News Source: Ophelia Keating. (November 18, 2026). Integrating PrEP into Iran Harm Reduction Offers Cost-Effective HIV Prevention. Scienmag.

Tags: antiretroviralscost-effectivenessdrop-in centersfemale sex workersGeneration Zharm reductionhealth system infrastructurehealthcare provider trainingHIV preventionIranmen who have sex with menpeople who inject drugspre-exposure prophylaxispublic health policysocial stigmatriangular clinicsvoluntary counseling and testing
Share12Tweet7Share2ShareShareShare1

Related Posts

No Correlation Found Between Interprofessional Training and Students Readiness for Collaboration

No Correlation Found Between Interprofessional Training and Students Readiness for Collaboration

November 18, 2026
Global Childhood Cancer Rates Rise as Registries Reveal Stark Survival Disparities

Global Childhood Cancer Rates Rise as Registries Reveal Stark Survival Disparities

November 18, 2026

Lower Common Iliac Vein Confluence Narrows Anterior L5-S1 Surgical Window

November 18, 2026

Smartphone Model Accurately Estimates Blood Pressure Under Real-World Daily Living Conditions

November 18, 2026

POPULAR NEWS

  • Level Two Brain Tumor Surgery in Mexico Linked to Higher Mortality

    Level Two Brain Tumor Surgery in Mexico Linked to Higher Mortality

    29 shares
    Share 12 Tweet 7
  • New Decision Aid Supports Patients Selecting Obstructive Sleep Apnea Treatment

    29 shares
    Share 12 Tweet 7
  • Thermodynamic Models Reveal Contrasting Atomic Ordering in Liquid Thallium Alloys

    29 shares
    Share 12 Tweet 7
  • Higher Professional Self-Efficacy Linked to Reduced Missed Nursing Care

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

No Correlation Found Between Interprofessional Training and Students Readiness for Collaboration

Global Childhood Cancer Rates Rise as Registries Reveal Stark Survival Disparities

Lower Common Iliac Vein Confluence Narrows Anterior L5-S1 Surgical Window

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.